NRX Pharmaceuticals(DE:B1Q)
€2.02-0.11 (-5.40%)
DE:B1Q
NRX Pharmaceuticals earnings date
€2.02
At close:-0.11 (-5.40%)
NRX Pharmaceuticals (B1Q) Q2 2022 Earnings Report
1 Followers
DE:B1Q Q2 2022 EPS Results
- Actual EPS
- -EUR 1.00
- Consensus EPS
- -EUR 0.91
- Beat/Miss
- Missed by -EUR 0.09
- One Year Ago EPS
- -EUR 58.35
DE:B1Q Q2 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/15/2022
- Time
- Before Open
- Conference Call
- Monday, August 15, 2022
DE:B1Q Upcoming Earnings
NRX Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:B1Q Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | -0.19- | -0.24 | ― | ― |
| Aug 17, 2026 | 2026 (Q2) | -0.10-0.40 | -0.89 | 55.10% (+0.49) | |
| May 18, 2026 | 2026 (Q1) | 0.19-0.04 | -0.31 | 88.24% (+0.27) | |
| Mar 24, 2026 | 2025 (Q4) | 0.010.01 | -0.66 | 101.38% (+0.67) | |
| Nov 17, 2025 | 2025 (Q3) | -0.02-0.24 | -0.14 | -80.00% (-0.11) | |
| Aug 18, 2025 | 2025 (Q2) | -0.14-0.89 | -0.68 | -30.67% (-0.21) | |
| May 15, 2025 | 2025 (Q1) | -0.26-0.31 | -0.67 | 54.05% (+0.36) | |
| Mar 17, 2025 | 2024 (Q4) | -0.33-0.66 | -0.45 | -44.80% (-0.20) | |
| Nov 14, 2024 | 2024 (Q3) | -0.50-0.14 | -0.64 | 78.57% (+0.50) | |
| Aug 13, 2024 | 2024 (Q2) | -0.63-0.68 | -1.09 | 37.50% (+0.41) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

